Peptide Library Canada: Research Reference Guide

[{"abbr":"ACE-031","name":"ACE-031","sub":"Activin Receptor Type IIB Inhibitor","desc":"ACE-031 (Activin Receptor Type IIB Inhibitor) appears in the historical reference index under Muscle. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Muscle. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Muscle","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"ACE-083","name":"ACE-083","sub":"Locally-Acting Follistatin Fusion Protein","desc":"ACE-083 (Locally-Acting Follistatin Fusion Protein) appears in the historical reference index under Muscle. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Muscle. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Muscle","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"ADA","name":"Adamax","sub":"Next-Generation Semax Derivative | Nootropic Neuropeptide","desc":"Adamax (Next-Generation Semax Derivative | Nootropic Neuropeptide) appears in the historical reference index under Cognitive Enhancement, neurological, mood-related. The original index associated it with these literature-review topics: Cognitive Enhancement research topic, Neuroplasticity Support research topic, Learning and Memory research topic, Stroke Recovery research topic, Oxidative Stress Protection research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Cognitive Enhancement research topic","Neuroplasticity Support research topic","Learning and Memory research topic","Stroke Recovery research topic","Oxidative Stress Protection research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Cognitive Enhancement, neurological, mood-related. Topics: Cognitive Enhancement research topic, Neuroplasticity Support research topic, Learning and Memory research topic, Stroke Recovery research topic, Oxidative Stress Protection research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"limited","category":"Cognitive Enhancement, neurological, mood-related","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Adipotide","name":"Adipotide (Prohibitin‑TP01)","sub":"Prohibitin‑Targeting Peptidomimetic | Experimental Anti‑Obesity","desc":"Adipotide (Prohibitin‑TP01) (Prohibitin‑Targeting Peptidomimetic | Experimental Anti‑Obesity) appears in the historical reference index under metabolic, Metabolism Support, appetite signaling. The original index associated it with these literature-review topics: White Adipose Reduction research topic, Insulin Sensitivity research topic, Peripheral Approach research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["White Adipose Reduction research topic","Insulin Sensitivity research topic","Peripheral Approach research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: metabolic, Metabolism Support, appetite signaling. Topics: White Adipose Reduction research topic, Insulin Sensitivity research topic, Peripheral Approach research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2–8°C (reconstituted)","level":"emerging","category":"metabolic, Metabolism Support, appetite signaling","source":"Historical index source label: both; primary-source verification required","url":""},{"abbr":"Alpha-MSH","name":"Alpha-MSH","sub":"Alpha-Melanocyte Stimulating Hormone","desc":"Alpha-MSH (Alpha-Melanocyte Stimulating Hormone) appears in the historical reference index under melanogenesis. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: melanogenesis. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"melanogenesis","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Ang-(1-7)","name":"Ang-(1-7)","sub":"Angiotensin 1-7 Peptide","desc":"Ang-(1-7) (Angiotensin 1-7 Peptide) appears in the historical reference index under Cardiovascular. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Cardiovascular. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Cardiovascular","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"AOD-9604","name":"AOD-9604","sub":"Advanced Obesity Drug | Modified hGH Fragment 176-191","desc":"AOD-9604 (Advanced Obesity Drug | Modified hGH Fragment 176-191) appears in the historical reference index under adipose metabolism. The original index associated it with these literature-review topics: adipose metabolism research topic, adipose metabolism / Lipolysis research topic, Lipogenesis Inhibition research topic, Metabolic Safety research topic, Joint research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["adipose metabolism research topic","adipose metabolism / Lipolysis research topic","Lipogenesis Inhibition research topic","Metabolic Safety research topic","Joint research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: adipose metabolism. Topics: adipose metabolism research topic, adipose metabolism / Lipolysis research topic, Lipogenesis Inhibition research topic, Metabolic Safety research topic, Joint research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"adipose metabolism","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/aod9604-5mg/"},{"abbr":"A2R","name":"Ara 290","sub":"Tissue-Protective Peptide | Innate Repair Receptor Agonist","desc":"Ara 290 (Tissue-Protective Peptide | Innate Repair Receptor Agonist) appears in the historical reference index under neurological, inflammation, tissue-repair. The original index associated it with these literature-review topics: Peripheral Nerve Regeneration research topic, Diabetic Neuropathy research, Central Nervous System Protection research topic, Cytokine Reduction research topic, Inflammatory Bowel Disease research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Peripheral Nerve Regeneration research topic","Diabetic Neuropathy research","Central Nervous System Protection research topic","Cytokine Reduction research topic","Inflammatory Bowel Disease research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: neurological, inflammation, tissue-repair. Topics: Peripheral Nerve Regeneration research topic, Diabetic Neuropathy research, Central Nervous System Protection research topic, Cytokine Reduction research topic, Inflammatory Bowel Disease research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"neurological, inflammation, tissue-repair","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"ARA-290","name":"ARA-290","sub":"Tissue-Protective Peptide | Innate Repair Receptor Agonist","desc":"ARA-290 (Tissue-Protective Peptide | Innate Repair Receptor Agonist) appears in the historical reference index under Inflammation. The original index associated it with these literature-review topics: Neuroprotection research topic, Peripheral Nerve Regeneration research topic, Diabetic Neuropathy research, Central Nervous System Protection research topic, inflammation research topic, tissue-repair research topic, Autoimmune research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Neuroprotection research topic","Peripheral Nerve Regeneration research topic","Diabetic Neuropathy research","Central Nervous System Protection research topic","inflammation research topic","tissue-repair research topic","Autoimmune research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Inflammation. Topics: Neuroprotection research topic, Peripheral Nerve Regeneration research topic, Diabetic Neuropathy research, Central Nervous System Protection research topic, inflammation research topic, tissue-repair research topic, Autoimmune research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"Inflammation","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"BPC-157","name":"BPC-157","sub":"Body Protection Compound-157 | Pentadecapeptide","desc":"BPC-157 (Body Protection Compound-157 | Pentadecapeptide) appears in the historical reference index under Healing. The original index associated it with these literature-review topics: Wound Healing research topic, Tendon Healing research topic, Muscle Recovery research topic, Angiogenesis research topic, Neurological research topic, Gastrointestinal research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Wound Healing research topic","Tendon Healing research topic","Muscle Recovery research topic","Angiogenesis research topic","Neurological research topic","Gastrointestinal research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: Healing. Topics: Wound Healing research topic, Tendon Healing research topic, Muscle Recovery research topic, Angiogenesis research topic, Neurological research topic, Gastrointestinal research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-6°C","level":"extensive","category":"Healing","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/bpc-157/"},{"abbr":"BPC-157 Arginate","name":"BPC-157 Arginate","sub":"BPC-157 Arginate (Injectable Form)","desc":"BPC-157 Arginate (BPC-157 Arginate (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Room temperature or refrigerated","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"CAG","name":"Cagrilintide","sub":"Long-Acting Amylin Receptor Agonist | metabolic & Diabetes","desc":"Cagrilintide (Long-Acting Amylin Receptor Agonist | metabolic & Diabetes) appears in the historical reference index under metabolic, Metabolism Support, appetite signaling. The original index associated it with these literature-review topics: Superior Obesity research, Type 2 Diabetes Weight Management research topic, Sustained Weight Maintenance research topic, Glucose Control Enhancement research topic, Insulin Sensitivity Improvement research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Superior Obesity research","Type 2 Diabetes Weight Management research topic","Sustained Weight Maintenance research topic","Glucose Control Enhancement research topic","Insulin Sensitivity Improvement research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: metabolic, Metabolism Support, appetite signaling. Topics: Superior Obesity research, Type 2 Diabetes Weight Management research topic, Sustained Weight Maintenance research topic, Glucose Control Enhancement research topic, Insulin Sensitivity Improvement research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"-20°C","level":"well","category":"metabolic, Metabolism Support, appetite signaling","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"CER","name":"Cerebrolysin","sub":"Neuropeptide Preparation | Neurological Recovery","desc":"Cerebrolysin (Neuropeptide Preparation | Neurological Recovery) appears in the historical reference index under Cognitive Enhancement, neurological, Recovery. The original index associated it with these literature-review topics: Alzheimer's Disease – Mixed Evidence research topic, Vascular Dementia – Established Efficacy research topic, Post-Stroke Cognitive Recovery research topic, Acute Stroke – Evidence Mixed research topic, Traumatic Brain Injury – Strong Evidence research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Alzheimer's Disease – Mixed Evidence research topic","Vascular Dementia – Established Efficacy research topic","Post-Stroke Cognitive Recovery research topic","Acute Stroke – Evidence Mixed research topic","Traumatic Brain Injury – Strong Evidence research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Cognitive Enhancement, neurological, Recovery. Topics: Alzheimer's Disease – Mixed Evidence research topic, Vascular Dementia – Established Efficacy research topic, Post-Stroke Cognitive Recovery research topic, Acute Stroke – Evidence Mixed research topic, Traumatic Brain Injury – Strong Evidence research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Room temp ≤25°C","level":"well","category":"Cognitive Enhancement, neurological, Recovery","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Cetrorelix","name":"Cetrorelix","sub":"Cetrorelix (GnRH Antagonist)","desc":"Cetrorelix (Cetrorelix (GnRH Antagonist)) appears in the historical reference index under Hormonal. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Hormonal. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Hormonal","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"CGRP","name":"CGRP","sub":"Calcitonin Gene-Related Peptide","desc":"CGRP (Calcitonin Gene-Related Peptide) appears in the historical reference index under Pain. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Pain. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Pain","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"CJC-1295 (no DAC)","name":"CJC-1295 (no DAC)","sub":"Short-Acting Growth Hormone Releasing Hormone Analog | Modified GRF 1-29","desc":"CJC-1295 (no DAC) (Short-Acting Growth Hormone Releasing Hormone Analog | Modified GRF 1-29) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Growth Hormone Increase research topic, Muscle Growth research topic, adipose metabolism research topic, Recovery Enhancement research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Growth Hormone Increase research topic","Muscle Growth research topic","adipose metabolism research topic","Recovery Enhancement research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Growth Hormone. Topics: Growth Hormone Increase research topic, Muscle Growth research topic, adipose metabolism research topic, Recovery Enhancement research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Growth Hormone","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/cjc-1295-no-dac/"},{"abbr":"CJC-1295 (DAC)","name":"CJC-1295 with DAC","sub":"Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release","desc":"CJC-1295 with DAC (Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Growth Hormone Increase research topic, Muscle Growth research topic, adipose metabolism research topic, Anti-Aging research topic, Recovery Enhancement research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Growth Hormone Increase research topic","Muscle Growth research topic","adipose metabolism research topic","Anti-Aging research topic","Recovery Enhancement research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Growth Hormone. Topics: Growth Hormone Increase research topic, Muscle Growth research topic, adipose metabolism research topic, Anti-Aging research topic, Recovery Enhancement research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Growth Hormone","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/cjc-1295-with-dac/"},{"abbr":"Colivelin","name":"Colivelin","sub":"Colivelin (Humanin-STAT3 Fusion Peptide)","desc":"Colivelin (Colivelin (Humanin-STAT3 Fusion Peptide)) appears in the historical reference index under Longevity. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Longevity. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Longevity","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Cortagen","name":"Cortagen","sub":"Cortagen (AEDG Neural Bioregulator)","desc":"Cortagen (Cortagen (AEDG Neural Bioregulator)) appears in the historical reference index under Cognitive. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Cognitive. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Cognitive","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Dihexa","name":"Dihexa","sub":"Synaptogenic Peptide | Cognitive Enhancement & Neuroprotection","desc":"Dihexa (Synaptogenic Peptide | Cognitive Enhancement & Neuroprotection) appears in the historical reference index under Cognitive. The original index associated it with these literature-review topics: Cognitive research topic, Memory Enhancement research topic, Learning Acceleration research topic, Cognitive Recovery research topic, Neuroprotection research topic, Neuroplasticity research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Cognitive research topic","Memory Enhancement research topic","Learning Acceleration research topic","Cognitive Recovery research topic","Neuroprotection research topic","Neuroplasticity research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Cognitive. Topics: Cognitive research topic, Memory Enhancement research topic, Learning Acceleration research topic, Cognitive Recovery research topic, Neuroprotection research topic, Neuroplasticity research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Room temp (oral) / 2-8°C (DMSO stock)","level":"emerging","category":"Cognitive","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"DSIP","name":"DSIP","sub":"Delta Sleep-Inducing Peptide | Sleep & Stress Modulator","desc":"DSIP (Delta Sleep-Inducing Peptide | Sleep & Stress Modulator) appears in the historical reference index under Sleep. The original index associated it with these literature-review topics: Sleep research topic, Deep Sleep Enhancement research topic, Sleep Efficiency research topic, Natural Sleep Architecture research topic, Mood research topic, Metabolic research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Sleep research topic","Deep Sleep Enhancement research topic","Sleep Efficiency research topic","Natural Sleep Architecture research topic","Mood research topic","Metabolic research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Sleep. Topics: Sleep research topic, Deep Sleep Enhancement research topic, Sleep Efficiency research topic, Natural Sleep Architecture research topic, Mood research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"Sleep","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/dsip/"},{"abbr":"Epithalon","name":"Epithalon","sub":"Synthetic Pineal Tetrapeptide | Telomerase Activator & Anti-Aging","desc":"Epithalon (Synthetic Pineal Tetrapeptide | Telomerase Activator & Anti-Aging) appears in the historical reference index under Anti-Aging. The original index associated it with these literature-review topics: Anti Aging research topic, Telomere Extension research topic, Cellular Rejuvenation research topic, Lifespan Extension research topic, Neuroprotection research topic, Immunity research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Anti Aging research topic","Telomere Extension research topic","Cellular Rejuvenation research topic","Lifespan Extension research topic","Neuroprotection research topic","Immunity research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Anti-Aging. Topics: Anti Aging research topic, Telomere Extension research topic, Cellular Rejuvenation research topic, Lifespan Extension research topic, Neuroprotection research topic, Immunity research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Anti-Aging","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/epithalon-10mg/"},{"abbr":"EPO Helix-B","name":"EPO Helix-B","sub":"Erythropoietin Helix-B Surface Peptide","desc":"EPO Helix-B (Erythropoietin Helix-B Surface Peptide) appears in the historical reference index under Performance. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Performance. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Performance","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"FBA","name":"Fat Blaster","sub":"Enhanced Lipotropic Blend | L-Carnitine + MIC + B Vitamins + NADH","desc":"Fat Blaster (Enhanced Lipotropic Blend | L-Carnitine + MIC + B Vitamins + NADH) appears in the historical reference index under Fat Metabolism, Insulin Sensitivity, Energy & Metabolism. The original index associated it with these literature-review topics: Fat Oxidation Support research topic, Liver Lipid Metabolism research topic, Insulin Sensitivity Support research topic, Metabolic Function research topic, Cellular Energy Production research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Fat Oxidation Support research topic","Liver Lipid Metabolism research topic","Insulin Sensitivity Support research topic","Metabolic Function research topic","Cellular Energy Production research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Fat Metabolism, Insulin Sensitivity, Energy & Metabolism. Topics: Fat Oxidation Support research topic, Liver Lipid Metabolism research topic, Insulin Sensitivity Support research topic, Metabolic Function research topic, Cellular Energy Production research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C (refrigerated)","level":"limited","category":"Fat Metabolism, Insulin Sensitivity, Energy & Metabolism","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Follistatin 344","name":"Follistatin 344","sub":"Myostatin Inhibitor | TGF-β Antagonist for Muscle Research","desc":"Follistatin 344 (Myostatin Inhibitor | TGF-β Antagonist for Muscle Research) appears in the historical reference index under Muscle Growth, Recovery. The original index associated it with these literature-review topics: Myostatin Inhibition research topic, Activin A Blockade research topic, Satellite Cell Activation research topic, Muscular Dystrophy Research, Muscle Wasting Conditions research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Myostatin Inhibition research topic","Activin A Blockade research topic","Satellite Cell Activation research topic","Muscular Dystrophy Research","Muscle Wasting Conditions research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Muscle Growth, Recovery. Topics: Myostatin Inhibition research topic, Activin A Blockade research topic, Satellite Cell Activation research topic, Muscular Dystrophy Research, Muscle Wasting Conditions research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"-20°C (lyophilized); 2-8°C (reconstituted)","level":"emerging","category":"Muscle Growth, Recovery","source":"Historical index source label: both; primary-source verification required","url":""},{"abbr":"FOX","name":"FOXO4-DRI","sub":"Senolytic Peptide | FOXO4-p53 Disruption for Cellular Aging Research","desc":"FOXO4-DRI (Senolytic Peptide | FOXO4-p53 Disruption for Cellular Aging Research) appears in the historical reference index under Anti-Aging, Cellular Health, inflammation. The original index associated it with these literature-review topics: Senescent Cell Clearance research topic, Tissue Rejuvenation research topic, Cellular Health research topic, SASP Reduction research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Senescent Cell Clearance research topic","Tissue Rejuvenation research topic","Cellular Health research topic","SASP Reduction research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Anti-Aging, Cellular Health, inflammation. Topics: Senescent Cell Clearance research topic, Tissue Rejuvenation research topic, Cellular Health research topic, SASP Reduction research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"-20°C (lyophilized)","level":"emerging","category":"Anti-Aging, Cellular Health, inflammation","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Fragment 176-191","name":"Fragment 176-191","sub":"Advanced Obesity Drug | Modified hGH Fragment 176-191","desc":"Fragment 176-191 (Advanced Obesity Drug | Modified hGH Fragment 176-191) appears in the historical reference index under adipose metabolism. The original index associated it with these literature-review topics: adipose metabolism research topic, adipose metabolism / Lipolysis research topic, Lipogenesis Inhibition research topic, Metabolic Safety research topic, Joint research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["adipose metabolism research topic","adipose metabolism / Lipolysis research topic","Lipogenesis Inhibition research topic","Metabolic Safety research topic","Joint research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: adipose metabolism. Topics: adipose metabolism research topic, adipose metabolism / Lipolysis research topic, Lipogenesis Inhibition research topic, Metabolic Safety research topic, Joint research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"adipose metabolism","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/hgh-fragment/"},{"abbr":"GHK-Cu","name":"GHK-Cu","sub":"GHK-Cu (Injectable Form)","desc":"GHK-Cu (GHK-Cu (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/ghk-cu/"},{"abbr":"Ghrelin","name":"Ghrelin","sub":"Ghrelin Peptide Hormone (Acylated)","desc":"Ghrelin (Ghrelin Peptide Hormone (Acylated)) appears in the historical reference index under Metabolic. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Metabolic. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Metabolic","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"GHRH 1-44","name":"GHRH 1-44","sub":"Growth Hormone Releasing Hormone 1-44","desc":"GHRH 1-44 (Growth Hormone Releasing Hormone 1-44) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Growth Hormone. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Growth Hormone","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"GHRP-1","name":"GHRP-1","sub":"Growth Hormone Releasing Peptide-1","desc":"GHRP-1 (Growth Hormone Releasing Peptide-1) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Growth Hormone. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Growth Hormone","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"GHRP-2","name":"GHRP-2","sub":"Growth Hormone Releasing Peptide-2","desc":"GHRP-2 (Growth Hormone Releasing Peptide-2) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Growth Hormone. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Growth Hormone","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"GHRP-6","name":"GHRP-6","sub":"Growth Hormone Releasing Peptide-6","desc":"GHRP-6 (Growth Hormone Releasing Peptide-6) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Growth Hormone. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Growth Hormone","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"GPL","name":"Glow Protocol","sub":"Multi-Peptide Skin Rejuvenation Complex | Regenerative Blend","desc":"Glow Protocol (Multi-Peptide Skin Rejuvenation Complex | Regenerative Blend) appears in the historical reference index under Skin Health, tissue-repair, Cellular Health. The original index associated it with these literature-review topics: Skin Rejuvenation research topic, Collagen Synthesis research topic, Anti-Aging Support research topic, Wound Healing research topic, Tissue Regeneration research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Skin Rejuvenation research topic","Collagen Synthesis research topic","Anti-Aging Support research topic","Wound Healing research topic","Tissue Regeneration research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Skin Health, tissue-repair, Cellular Health. Topics: Skin Rejuvenation research topic, Collagen Synthesis research topic, Anti-Aging Support research topic, Wound Healing research topic, Tissue Regeneration research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"limited","category":"Skin Health, tissue-repair, Cellular Health","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/glow-70mg/"},{"abbr":"GLP-2","name":"GLP-2","sub":"Glucagon-Like Peptide-2 (Teduglutide)","desc":"GLP-2 (Glucagon-Like Peptide-2 (Teduglutide)) appears in the historical reference index under Healing. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Healing. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Healing","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"GLU","name":"Glutathione","sub":"Master Antioxidant | Tripeptide | GSH","desc":"Glutathione (Master Antioxidant | Tripeptide | GSH) appears in the historical reference index under Antioxidant Support, Detoxification, Immune Function. The original index associated it with these literature-review topics: Master Antioxidant research topic, Antioxidant Recycling research topic, Phase II Liver Support research topic, Heavy Metal Binding research topic, Lymphocyte Support research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Master Antioxidant research topic","Antioxidant Recycling research topic","Phase II Liver Support research topic","Heavy Metal Binding research topic","Lymphocyte Support research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Antioxidant Support, Detoxification, Immune Function. Topics: Master Antioxidant research topic, Antioxidant Recycling research topic, Phase II Liver Support research topic, Heavy Metal Binding research topic, Lymphocyte Support research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"well","category":"Antioxidant Support, Detoxification, Immune Function","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/glutathione-1500mg/"},{"abbr":"Gonadorelin","name":"Gonadorelin","sub":"Gonadorelin Acetate (GnRH Analogue)","desc":"Gonadorelin (Gonadorelin Acetate (GnRH Analogue)) appears in the historical reference index under Hormonal. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Hormonal. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Hormonal","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"HCG","name":"HCG (Human Chorionic Gonadotropin)","sub":"Gonadotropin Hormone | LH Receptor Agonist","desc":"HCG (Human Chorionic Gonadotropin) (Gonadotropin Hormone | LH Receptor Agonist) appears in the historical reference index under Growth Hormone, Recovery, Body Composition. The original index associated it with these literature-review topics: Hypogonadotropic Hypogonadism research topic, Testosterone Support research topic, Fertility Preservation research topic, TRT Adjunct research topic, Cryptorchidism research. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Hypogonadotropic Hypogonadism research topic","Testosterone Support research topic","Fertility Preservation research topic","TRT Adjunct research topic","Cryptorchidism research"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: Growth Hormone, Recovery, Body Composition. Topics: Hypogonadotropic Hypogonadism research topic, Testosterone Support research topic, Fertility Preservation research topic, TRT Adjunct research topic, Cryptorchidism research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C after reconstitution","level":"extensive","category":"Growth Hormone, Recovery, Body Composition","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Hexarelin","name":"Hexarelin (Examorelin)","sub":"Hexapeptide GHRP | Growth Hormone Release & Cardioprotection","desc":"Hexarelin (Examorelin) (Hexapeptide GHRP | Growth Hormone Release & Cardioprotection) appears in the historical reference index under Hormonal Balance, Cardiovascular, neurological. The original index associated it with these literature-review topics: Growth Hormone Release research topic, IGF-1 Elevation research topic, Pulsatile GH Pattern research topic, Cardioprotection research topic, Anti-Fibrotic Effects research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Growth Hormone Release research topic","IGF-1 Elevation research topic","Pulsatile GH Pattern research topic","Cardioprotection research topic","Anti-Fibrotic Effects research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Hormonal Balance, Cardiovascular, neurological. Topics: Growth Hormone Release research topic, IGF-1 Elevation research topic, Pulsatile GH Pattern research topic, Cardioprotection research topic, Anti-Fibrotic Effects research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Hormonal Balance, Cardiovascular, neurological","source":"Historical index source label: both; primary-source verification required","url":""},{"abbr":"HGH Fragment","name":"HGH Fragment 176-191","sub":"Human Growth Hormone | 191aa Recombinant Growth Hormone","desc":"HGH Fragment 176-191 (Human Growth Hormone | 191aa Recombinant Growth Hormone) appears in the historical reference index under metabolic. The original index associated it with these literature-review topics: adipose metabolism research topic, Lipolysis research topic, Metabolic Enhancement research topic, Body Composition research topic. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["adipose metabolism research topic","Lipolysis research topic","Metabolic Enhancement research topic","Body Composition research topic"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: metabolic. Topics: adipose metabolism research topic, Lipolysis research topic, Metabolic Enhancement research topic, Body Composition research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C (refrigerated)","level":"Well Researched","category":"metabolic","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/hgh-fragment/"},{"abbr":"Humanin","name":"Humanin","sub":"Humanin Mitochondrial Peptide","desc":"Humanin (Humanin Mitochondrial Peptide) appears in the historical reference index under Longevity. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Longevity. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Longevity","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"IGF-1 LR3","name":"IGF-1 LR3","sub":"Modified Growth Factor Analog | Research Chemical Only","desc":"IGF-1 LR3 (Modified Growth Factor Analog | Research Chemical Only) appears in the historical reference index under Muscle. The original index associated it with these literature-review topics: Muscle Growth research topic, Muscle Hypertrophy research topic, Anti-Catabolic Effects research topic, Hyperplasia Induction research topic, tissue-repair research topic, Metabolic research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Muscle Growth research topic","Muscle Hypertrophy research topic","Anti-Catabolic Effects research topic","Hyperplasia Induction research topic","tissue-repair research topic","Metabolic research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Muscle. Topics: Muscle Growth research topic, Muscle Hypertrophy research topic, Anti-Catabolic Effects research topic, Hyperplasia Induction research topic, tissue-repair research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"-20°C to -80°C (lyophilized)","level":"limited","category":"Muscle","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/igf-1-lr3-1-mg/"},{"abbr":"IGF-2","name":"IGF-2","sub":"Insulin-like Growth Factor 2","desc":"IGF-2 (Insulin-like Growth Factor 2) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Growth Hormone. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Growth Hormone","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Insulin B9-23","name":"Insulin B9-23","sub":"Insulin B Chain Fragment B9-23","desc":"Insulin B9-23 (Insulin B Chain Fragment B9-23) appears in the historical reference index under Metabolic. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Metabolic. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Metabolic","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Ipamorelin","name":"Ipamorelin","sub":"Growth Hormone Secretagogue | Selective GHRP","desc":"Ipamorelin (Growth Hormone Secretagogue | Selective GHRP) appears in the historical reference index under Growth Hormone. The original index associated it with these literature-review topics: Growth Hormone research topic, Natural GH Stimulation research topic, IGF-1 Enhancement research topic, Anti-Aging Benefits research topic, Body Composition research topic, Recovery research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Growth Hormone research topic","Natural GH Stimulation research topic","IGF-1 Enhancement research topic","Anti-Aging Benefits research topic","Body Composition research topic","Recovery research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Growth Hormone. Topics: Growth Hormone research topic, Natural GH Stimulation research topic, IGF-1 Enhancement research topic, Anti-Aging Benefits research topic, Body Composition research topic, Recovery research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Growth Hormone","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/ipamorelin/"},{"abbr":"KIS","name":"Kisspeptin","sub":"KISS1 Gene Product | Reproductive Neuropeptide","desc":"Kisspeptin (KISS1 Gene Product | Reproductive Neuropeptide) appears in the historical reference index under Reproductive Health, reproductive signaling, Metabolism Support. The original index associated it with these literature-review topics: Hypogonadotropic Hypogonadism research topic, IVF Ovulation Trigger research topic, Hypothalamic Amenorrhea research topic, Hypoactive reproductive signaling research topic, reproductive signaling research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Hypogonadotropic Hypogonadism research topic","IVF Ovulation Trigger research topic","Hypothalamic Amenorrhea research topic","Hypoactive reproductive signaling research topic","reproductive signaling research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Reproductive Health, reproductive signaling, Metabolism Support. Topics: Hypogonadotropic Hypogonadism research topic, IVF Ovulation Trigger research topic, Hypothalamic Amenorrhea research topic, Hypoactive reproductive signaling research topic, reproductive signaling research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"Reproductive Health, reproductive signaling, Metabolism Support","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/kisspeptin-10mg/"},{"abbr":"Kisspeptin-10","name":"Kisspeptin-10","sub":"KISS1 Gene Product | Reproductive Neuropeptide","desc":"Kisspeptin-10 (KISS1 Gene Product | Reproductive Neuropeptide) appears in the historical reference index under Hormonal. The original index associated it with these literature-review topics: Reproductive research topic, Hypogonadotropic Hypogonadism research topic, IVF Ovulation Trigger research topic, Hypothalamic Amenorrhea research topic, reproductive signaling research topic, Metabolic research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Reproductive research topic","Hypogonadotropic Hypogonadism research topic","IVF Ovulation Trigger research topic","Hypothalamic Amenorrhea research topic","reproductive signaling research topic","Metabolic research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Hormonal. Topics: Reproductive research topic, Hypogonadotropic Hypogonadism research topic, IVF Ovulation Trigger research topic, Hypothalamic Amenorrhea research topic, reproductive signaling research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"Hormonal","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/kisspeptin-10mg/"},{"abbr":"Kisspeptin-54","name":"Kisspeptin-54","sub":"KISS1 Gene Product | Reproductive Neuropeptide","desc":"Kisspeptin-54 (KISS1 Gene Product | Reproductive Neuropeptide) appears in the historical reference index under Hormonal. The original index associated it with these literature-review topics: Reproductive research topic, Hypogonadotropic Hypogonadism research topic, IVF Ovulation Trigger research topic, Hypothalamic Amenorrhea research topic, reproductive signaling research topic, Metabolic research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Reproductive research topic","Hypogonadotropic Hypogonadism research topic","IVF Ovulation Trigger research topic","Hypothalamic Amenorrhea research topic","reproductive signaling research topic","Metabolic research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Hormonal. Topics: Reproductive research topic, Hypogonadotropic Hypogonadism research topic, IVF Ovulation Trigger research topic, Hypothalamic Amenorrhea research topic, reproductive signaling research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"Hormonal","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"KK-10","name":"KK-10","sub":"Four-Peptide Regenerative Blend | GHK-Cu + TB-500 + BPC-157 + KPV","desc":"KK-10 (Four-Peptide Regenerative Blend | GHK-Cu + TB-500 + BPC-157 + KPV) appears in the historical reference index under Antimicrobial. The original index associated it with these literature-review topics: Wound Healing research topic, Multi-Modal Healing research topic, Enhanced Tolerability research topic, KPV may reduce injection site reactions compared to GLOW research topic, Convenience Factor research topic, Single injection versus four separate peptides research topic, Recovery research topic, inflammation research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Wound Healing research topic","Multi-Modal Healing research topic","Enhanced Tolerability research topic","KPV may reduce injection site reactions compared to GLOW research topic","Convenience Factor research topic","Single injection versus four separate peptides research topic","Recovery research topic","inflammation research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Antimicrobial. Topics: Wound Healing research topic, Multi-Modal Healing research topic, Enhanced Tolerability research topic, KPV may reduce injection site reactions compared to GLOW research topic, Convenience Factor research topic, Single injection versus four separate peptides research topic, Recovery research topic, inflammation research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"limited","category":"Antimicrobial","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/klow-80mg/"},{"abbr":"KPL","name":"KLOW Protocol","sub":"inflammation Tripeptide | Alpha-MSH Fragment","desc":"KLOW Protocol (inflammation Tripeptide | Alpha-MSH Fragment) appears in the historical reference index under Wound Healing, Recovery, inflammation. The original index associated it with these literature-review topics: Multi-Modal Healing research topic, Enhanced Tolerability research topic, Convenience Factor research topic, Post-Surgical Recovery research topic, Sports Injury Support research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Multi-Modal Healing research topic","Enhanced Tolerability research topic","Convenience Factor research topic","Post-Surgical Recovery research topic","Sports Injury Support research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Wound Healing, Recovery, inflammation. Topics: Multi-Modal Healing research topic, Enhanced Tolerability research topic, Convenience Factor research topic, Post-Surgical Recovery research topic, Sports Injury Support research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"Wound Healing, Recovery, inflammation","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"KPV","name":"KPV","sub":"inflammation Tripeptide | Alpha-MSH Fragment","desc":"KPV (inflammation Tripeptide | Alpha-MSH Fragment) appears in the historical reference index under inflammation, Gut Health, Immune Function. The original index associated it with these literature-review topics: Systemic Inflammation research topic, Autoimmune Modulation research topic, Joint Inflammation research topic, IBD Support research topic, Intestinal Barrier research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Systemic Inflammation research topic","Autoimmune Modulation research topic","Joint Inflammation research topic","IBD Support research topic","Intestinal Barrier research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: inflammation, Gut Health, Immune Function. Topics: Systemic Inflammation research topic, Autoimmune Modulation research topic, Joint Inflammation research topic, IBD Support research topic, Intestinal Barrier research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"inflammation, Gut Health, Immune Function","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/kpv-10mg/"},{"abbr":"L-Carnitine","name":"L-Carnitine","sub":"Amino Acid Derivative | Energy & Fat Metabolism","desc":"L-Carnitine (Amino Acid Derivative | Energy & Fat Metabolism) appears in the historical reference index under metabolic, Metabolism Support, Cardiovascular. The original index associated it with these literature-review topics: Fat Metabolism & metabolic research topic, Mitochondrial Energy Support research topic, Heart Health research topic, Cognitive Function (ALCAR) research topic, Exercise Recovery research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Fat Metabolism & metabolic research topic","Mitochondrial Energy Support research topic","Heart Health research topic","Cognitive Function (ALCAR) research topic","Exercise Recovery research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: metabolic, Metabolism Support, Cardiovascular. Topics: Fat Metabolism & metabolic research topic, Mitochondrial Energy Support research topic, Heart Health research topic, Cognitive Function (ALCAR) research topic, Exercise Recovery research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Room temp (unopened) / 2-8°C (opened)","level":"well","category":"metabolic, Metabolism Support, Cardiovascular","source":"Historical index source label: both; primary-source verification required","url":""},{"abbr":"LEAP-2","name":"LEAP-2","sub":"Liver-Expressed Antimicrobial Peptide 2","desc":"LEAP-2 (Liver-Expressed Antimicrobial Peptide 2) appears in the historical reference index under Metabolic. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Metabolic. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Metabolic","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Leu-Enkephalin","name":"Leu-Enkephalin","sub":"Leucine-Enkephalin (Endogenous Opioid)","desc":"Leu-Enkephalin (Leucine-Enkephalin (Endogenous Opioid)) appears in the historical reference index under Pain. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Pain. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Pain","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"LIP","name":"Lipo-C","sub":"Lipotropic Injection | MIC + B Vitamins","desc":"Lipo-C (Lipotropic Injection | MIC + B Vitamins) appears in the historical reference index under Metabolic Health, adipose metabolism, Energy & Metabolism. The original index associated it with these literature-review topics: Liver Function Support research topic, Methylation Support research topic, Insulin Sensitivity research topic, Fat Metabolism Support research topic, Modest Effects research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Liver Function Support research topic","Methylation Support research topic","Insulin Sensitivity research topic","Fat Metabolism Support research topic","Modest Effects research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Metabolic Health, adipose metabolism, Energy & Metabolism. Topics: Liver Function Support research topic, Methylation Support research topic, Insulin Sensitivity research topic, Fat Metabolism Support research topic, Modest Effects research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Room temp or refrigerated","level":"limited","category":"Metabolic Health, adipose metabolism, Energy & Metabolism","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Liraglutide","name":"Liraglutide","sub":"Liraglutide (GLP-1 Receptor Agonist)","desc":"Liraglutide (Liraglutide (GLP-1 Receptor Agonist)) appears in the historical reference index under metabolic. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: metabolic. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"metabolic","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"LL-37","name":"LL-37","sub":"LL-37 (Injectable Form)","desc":"LL-37 (LL-37 (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"MAZ","name":"Mazdutide","sub":"Dual GLP-1/Glucagon Receptor Agonist | metabolic & Diabetes","desc":"Mazdutide (Dual GLP-1/Glucagon Receptor Agonist | metabolic & Diabetes) appears in the historical reference index under metabolic, Diabetes, Cardiovascular. The original index associated it with these literature-review topics: Severe Obesity Management research topic, Metabolic Syndrome Improvement research topic, Liver Fat Reduction research topic, Type 2 Diabetes Management research topic, Dual Endpoint Achievement research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Severe Obesity Management research topic","Metabolic Syndrome Improvement research topic","Liver Fat Reduction research topic","Type 2 Diabetes Management research topic","Dual Endpoint Achievement research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: metabolic, Diabetes, Cardiovascular. Topics: Severe Obesity Management research topic, Metabolic Syndrome Improvement research topic, Liver Fat Reduction research topic, Type 2 Diabetes Management research topic, Dual Endpoint Achievement research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C / -20°C (lyophilized)","level":"extensive","category":"metabolic, Diabetes, Cardiovascular","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Melanotan II","name":"Melanotan II","sub":"Synthetic Melanocortin Peptide | melanogenesis & reproductive signaling","desc":"Melanotan II (Synthetic Melanocortin Peptide | melanogenesis & reproductive signaling) appears in the historical reference index under melanogenesis. The original index associated it with these literature-review topics: Skin Health research topic, UV-Free melanogenesis research topic, Photoprotection research topic, Even Pigmentation research topic, Hormonal research topic, Metabolic research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Skin Health research topic","UV-Free melanogenesis research topic","Photoprotection research topic","Even Pigmentation research topic","Hormonal research topic","Metabolic research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: melanogenesis. Topics: Skin Health research topic, UV-Free melanogenesis research topic, Photoprotection research topic, Even Pigmentation research topic, Hormonal research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"melanogenesis","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/melanotan-mt-ii/"},{"abbr":"MK-677","name":"MK-677","sub":"MK-677 (Injectable Form)","desc":"MK-677 (MK-677 (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Room temperature","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"MOTS-c","name":"MOTS-c","sub":"Mice | Daily administration during pregnancy | Throughout pregnancy | Alleviated hyperglycemia, improved maternal-fetal outcomes","desc":"MOTS-c (Mice | Daily administration during pregnancy | Throughout pregnancy | Alleviated hyperglycemia, improved maternal-fetal outcomes) appears in the historical reference index under Quick Start Guide. The original index associated it with these literature-review topics: Metabolic research topic, Insulin Resistance research topic, Type 2 Diabetes research topic, Obesity Prevention research topic, Anti Aging research topic, Exercise research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Metabolic research topic","Insulin Resistance research topic","Type 2 Diabetes research topic","Obesity Prevention research topic","Anti Aging research topic","Exercise research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: Quick Start Guide. Topics: Metabolic research topic, Insulin Resistance research topic, Type 2 Diabetes research topic, Obesity Prevention research topic, Anti Aging research topic, Exercise research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"Quick Start Guide","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/mots-c/"},{"abbr":"NAD+","name":"NAD+ (Nicotinamide Adenine Dinucleotide)","sub":"Essential Cellular Coenzyme | Anti-Aging Therapy","desc":"NAD+ (Nicotinamide Adenine Dinucleotide) (Essential Cellular Coenzyme | Anti-Aging Therapy) appears in the historical reference index under Longevity. The original index associated it with these literature-review topics: Anti-Aging research topic, Energy & Metabolism research topic, Cognitive Enhancement research topic, DNA Repair research topic, Mitochondrial Health research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Anti-Aging research topic","Energy & Metabolism research topic","Cognitive Enhancement research topic","DNA Repair research topic","Mitochondrial Health research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: Longevity. Topics: Anti-Aging research topic, Energy & Metabolism research topic, Cognitive Enhancement research topic, DNA Repair research topic, Mitochondrial Health research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"Longevity","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/nad-500mg/"},{"abbr":"NAP","name":"NAP","sub":"NAP (Injectable Form)","desc":"NAP (NAP (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"NC-17","name":"NC-17","sub":"NC-17 (Injectable Form)","desc":"NC-17 (NC-17 (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"Oral Semaglutide","name":"Oral Semaglutide","sub":"GLP-1 Receptor Agonist | metabolic & Diabetes","desc":"Oral Semaglutide (GLP-1 Receptor Agonist | metabolic & Diabetes) appears in the historical reference index under metabolic. The original index associated it with these literature-review topics: metabolic research topic, Clinically Significant Weight Reduction research topic, Appetite and Craving Control research topic, Sustained Weight Maintenance research topic, Diabetes research topic, Metabolic research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["metabolic research topic","Clinically Significant Weight Reduction research topic","Appetite and Craving Control research topic","Sustained Weight Maintenance research topic","Diabetes research topic","Metabolic research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: metabolic. Topics: metabolic research topic, Clinically Significant Weight Reduction research topic, Appetite and Craving Control research topic, Sustained Weight Maintenance research topic, Diabetes research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"metabolic","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"OXY","name":"Oxytocin","sub":"Neurohypophysial Peptide | Social Bonding & Reproductive Hormone","desc":"Oxytocin (Neurohypophysial Peptide | Social Bonding & Reproductive Hormone) appears in the historical reference index under Social, Mental, Reproductive Health. The original index associated it with these literature-review topics: Social Bonding and Trust research topic, Autism Spectrum Disorders research topic, Social Anxiety research topic, PTSD Therapy Augmentation research topic, Anxiety and Depression research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Social Bonding and Trust research topic","Autism Spectrum Disorders research topic","Social Anxiety research topic","PTSD Therapy Augmentation research topic","Anxiety and Depression research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: Social, Mental, Reproductive Health. Topics: Social Bonding and Trust research topic, Autism Spectrum Disorders research topic, Social Anxiety research topic, PTSD Therapy Augmentation research topic, Anxiety and Depression research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"Social, Mental, Reproductive Health","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"P21","name":"P21","sub":"P21 (Injectable Form)","desc":"P21 (P21 (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"PE","name":"PE-22-28 (Mini-Spadin)","sub":"TREK-1 Channel Blocker | Shortened Spadin Analog","desc":"PE-22-28 (Mini-Spadin) (TREK-1 Channel Blocker | Shortened Spadin Analog) appears in the historical reference index under mood-related, Cognitive Enhancement, Anxiety Relief. The original index associated it with these literature-review topics: Depression Research, Neurogenesis / Cognitive research topic, Anxiety Research, Neuroprotection / Stroke research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Depression Research","Neurogenesis / Cognitive research topic","Anxiety Research","Neuroprotection / Stroke research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: mood-related, Cognitive Enhancement, Anxiety Relief. Topics: Depression Research, Neurogenesis / Cognitive research topic, Anxiety Research, Neuroprotection / Stroke research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C (refrigerated)","level":"emerging","category":"mood-related, Cognitive Enhancement, Anxiety Relief","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"PEG","name":"PEG-MGF","sub":"Pegylated Mechano Growth Factor | IGF-1 Splice Variant","desc":"PEG-MGF (Pegylated Mechano Growth Factor | IGF-1 Splice Variant) appears in the historical reference index under Muscle Repair, Tissue Regeneration, Recovery. The original index associated it with these literature-review topics: Satellite Cell Activation research topic, Delayed Senescence research topic, Enhanced Fusion Potential research topic, Tendon Healing research topic, Bone Regeneration research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Satellite Cell Activation research topic","Delayed Senescence research topic","Enhanced Fusion Potential research topic","Tendon Healing research topic","Bone Regeneration research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Muscle Repair, Tissue Regeneration, Recovery. Topics: Satellite Cell Activation research topic, Delayed Senescence research topic, Enhanced Fusion Potential research topic, Tendon Healing research topic, Bone Regeneration research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C (reconstituted)","level":"limited","category":"Muscle Repair, Tissue Regeneration, Recovery","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"PIN","name":"Pinealon","sub":"Synthetic Tripeptide | Neuroprotection & Cognitive Enhancement","desc":"Pinealon (Synthetic Tripeptide | Neuroprotection & Cognitive Enhancement) appears in the historical reference index under neurological, Cognitive Enhancement, Anti-Aging. The original index associated it with these literature-review topics: Traumatic Brain Injury Recovery research topic, Cellular Neuroprotection research topic, Stroke Recovery Support research topic, Memory Enhancement research topic, NMDA Receptor Expression research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Traumatic Brain Injury Recovery research topic","Cellular Neuroprotection research topic","Stroke Recovery Support research topic","Memory Enhancement research topic","NMDA Receptor Expression research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: neurological, Cognitive Enhancement, Anti-Aging. Topics: Traumatic Brain Injury Recovery research topic, Cellular Neuroprotection research topic, Stroke Recovery Support research topic, Memory Enhancement research topic, NMDA Receptor Expression research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"neurological, Cognitive Enhancement, Anti-Aging","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"PN-1 Peptide","name":"PN-1 Peptide","sub":"Protease Nexin-1 Healing Peptide","desc":"PN-1 Peptide (Protease Nexin-1 Healing Peptide) appears in the historical reference index under Healing. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Healing. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Healing","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"PRO","name":"Prostamax","sub":"Synthetic Tetrapeptide | Prostate Bioregulator","desc":"Prostamax (Synthetic Tetrapeptide | Prostate Bioregulator) appears in the historical reference index under Prostate Health, Anti-Aging, Immune Support. The original index associated it with these literature-review topics: Chronic Prostatitis Management research topic, Tissue Regeneration research topic, Superior to Conventional Agents research topic, Chromatin Decondensation research topic, Epigenetic Modulation research topic. Its historical evidence label was 'limited'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Chronic Prostatitis Management research topic","Tissue Regeneration research topic","Superior to Conventional Agents research topic","Chromatin Decondensation research topic","Epigenetic Modulation research topic"],"evidence":"Historical label: limited — Limited published literature; independent review required","context":"Categories: Prostate Health, Anti-Aging, Immune Support. Topics: Chronic Prostatitis Management research topic, Tissue Regeneration research topic, Superior to Conventional Agents research topic, Chromatin Decondensation research topic, Epigenetic Modulation research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"limited","category":"Prostate Health, Anti-Aging, Immune Support","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"PT-141","name":"PT-141","sub":"Melanocortin Receptor Agonist | reproductive signaling","desc":"PT-141 (Melanocortin Receptor Agonist | reproductive signaling) appears in the historical reference index under reproductive signaling. The original index associated it with these literature-review topics: Hormonal research topic, Hypoactive reproductive signaling research topic, Erectile Dysfunction research topic, Female reproductive signaling research topic, Improves physiological and subjective arousal measures research topic, Mood research topic, Metabolic research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Hormonal research topic","Hypoactive reproductive signaling research topic","Erectile Dysfunction research topic","Female reproductive signaling research topic","Improves physiological and subjective arousal measures research topic","Mood research topic","Metabolic research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: reproductive signaling. Topics: Hormonal research topic, Hypoactive reproductive signaling research topic, Erectile Dysfunction research topic, Female reproductive signaling research topic, Improves physiological and subjective arousal measures research topic, Mood research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"reproductive signaling","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/pt-141/"},{"abbr":"PTH 1-34","name":"PTH 1-34","sub":"Parathyroid Hormone Fragment 1-34 (Teriparatide)","desc":"PTH 1-34 (Parathyroid Hormone Fragment 1-34 (Teriparatide)) appears in the historical reference index under Performance. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Performance. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Performance","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Relaxin-2","name":"Relaxin-2","sub":"Relaxin-2 Peptide Hormone","desc":"Relaxin-2 (Relaxin-2 Peptide Hormone) appears in the historical reference index under Cardiovascular. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Cardiovascular. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Cardiovascular","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Retatrutide","name":"Retatrutide","sub":"Triple GLP-1/GIP/Glucagon Agonist | metabolic & Diabetes","desc":"Retatrutide (Triple GLP-1/GIP/Glucagon Agonist | metabolic & Diabetes) appears in the historical reference index under metabolic. The original index associated it with these literature-review topics: metabolic research topic, Superior Weight Reduction research topic, Sustained Weight Management research topic, Triple Mechanism Obesity research, Diabetes research topic, Cardiovascular research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["metabolic research topic","Superior Weight Reduction research topic","Sustained Weight Management research topic","Triple Mechanism Obesity research","Diabetes research topic","Cardiovascular research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: metabolic. Topics: metabolic research topic, Superior Weight Reduction research topic, Sustained Weight Management research topic, Triple Mechanism Obesity research, Diabetes research topic, Cardiovascular research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"metabolic","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/glp-3-ret-5mg-retatrutide/"},{"abbr":"Selank","name":"Selank","sub":"Synthetic Tuftsin Analog | Anxiolytic & Nootropic Peptide","desc":"Selank (Synthetic Tuftsin Analog | Anxiolytic & Nootropic Peptide) appears in the historical reference index under Cognitive. The original index associated it with these literature-review topics: Anxiety research topic, Generalized Anxiety Disorder research topic, Post-Traumatic Stress Disorder research topic, Social Anxiety and Performance Stress research topic, Cognitive research topic, Immune research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Anxiety research topic","Generalized Anxiety Disorder research topic","Post-Traumatic Stress Disorder research topic","Social Anxiety and Performance Stress research topic","Cognitive research topic","Immune research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Cognitive. Topics: Anxiety research topic, Generalized Anxiety Disorder research topic, Post-Traumatic Stress Disorder research topic, Social Anxiety and Performance Stress research topic, Cognitive research topic, Immune research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Cognitive","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/selank-10mg/"},{"abbr":"Semaglutide","name":"Semaglutide","sub":"GLP-1 Receptor Agonist | metabolic & Diabetes","desc":"Semaglutide (GLP-1 Receptor Agonist | metabolic & Diabetes) appears in the historical reference index under metabolic. The original index associated it with these literature-review topics: metabolic research topic, Clinically Significant Weight Reduction research topic, Appetite and Craving Control research topic, Sustained Weight Maintenance research topic, Diabetes research topic, Metabolic research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["metabolic research topic","Clinically Significant Weight Reduction research topic","Appetite and Craving Control research topic","Sustained Weight Maintenance research topic","Diabetes research topic","Metabolic research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: metabolic. Topics: metabolic research topic, Clinically Significant Weight Reduction research topic, Appetite and Craving Control research topic, Sustained Weight Maintenance research topic, Diabetes research topic, Metabolic research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"metabolic","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Semax","name":"Semax","sub":"Semax (Injectable Form)","desc":"Semax (Semax (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/semax-5mg/"},{"abbr":"SER","name":"Sermorelin","sub":"GHRH 1-29 Analog | Growth Hormone Releasing Hormone","desc":"Sermorelin (GHRH 1-29 Analog | Growth Hormone Releasing Hormone) appears in the historical reference index under Muscle Growth, Anti-Aging, Hormonal Balance. The original index associated it with these literature-review topics: Lean Body Mass Enhancement research topic, IGF-1 Mediated Growth research topic, Athletic Performance Support research topic, Age-Related GH Decline Reversal research topic, Body Composition Improvement research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Lean Body Mass Enhancement research topic","IGF-1 Mediated Growth research topic","Athletic Performance Support research topic","Age-Related GH Decline Reversal research topic","Body Composition Improvement research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Muscle Growth, Anti-Aging, Hormonal Balance. Topics: Lean Body Mass Enhancement research topic, IGF-1 Mediated Growth research topic, Athletic Performance Support research topic, Age-Related GH Decline Reversal research topic, Body Composition Improvement research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Muscle Growth, Anti-Aging, Hormonal Balance","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"SHLP2","name":"SHLP2","sub":"Small Humanin-Like Peptide 2","desc":"SHLP2 (Small Humanin-Like Peptide 2) appears in the historical reference index under Longevity. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Longevity. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Longevity","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"SS-31","name":"SS-31","sub":"Mitochondrial-Targeted Peptide | Cardiolipin Protector","desc":"SS-31 (Mitochondrial-Targeted Peptide | Cardiolipin Protector) appears in the historical reference index under Longevity. The original index associated it with these literature-review topics: Mitochondrial research topic, Enhanced ATP Production research topic, Oxidative Stress Reduction research topic, Protects against reactive oxygen species at the source research topic, Mitochondrial Disease Support research topic, Shows promise for various mitochondrial disorders research topic, Cardiovascular research topic, Anti Aging research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Mitochondrial research topic","Enhanced ATP Production research topic","Oxidative Stress Reduction research topic","Protects against reactive oxygen species at the source research topic","Mitochondrial Disease Support research topic","Shows promise for various mitochondrial disorders research topic","Cardiovascular research topic","Anti Aging research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Longevity. Topics: Mitochondrial research topic, Enhanced ATP Production research topic, Oxidative Stress Reduction research topic, Protects against reactive oxygen species at the source research topic, Mitochondrial Disease Support research topic, Shows promise for various mitochondrial disorders research topic, Cardiovascular research topic, Anti Aging research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"emerging","category":"Longevity","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"SS","name":"SS-31 (Elamipretide)","sub":"Mitochondrial-Targeted Peptide | Cardiolipin Protector","desc":"SS-31 (Elamipretide) (Mitochondrial-Targeted Peptide | Cardiolipin Protector) appears in the historical reference index under Mitochondrial, Cardiovascular, Anti-Aging. The original index associated it with these literature-review topics: Enhanced ATP Production research topic, Oxidative Stress Reduction research topic, Mitochondrial Disease Support research topic, Cardiac Protection research topic, Heart Failure Support research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Enhanced ATP Production research topic","Oxidative Stress Reduction research topic","Mitochondrial Disease Support research topic","Cardiac Protection research topic","Heart Failure Support research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: Mitochondrial, Cardiovascular, Anti-Aging. Topics: Enhanced ATP Production research topic, Oxidative Stress Reduction research topic, Mitochondrial Disease Support research topic, Cardiac Protection research topic, Heart Failure Support research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"Mitochondrial, Cardiovascular, Anti-Aging","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Substance P","name":"Substance P","sub":"Substance P Neuropeptide","desc":"Substance P (Substance P Neuropeptide) appears in the historical reference index under Pain. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Pain. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Pain","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"SUR","name":"Survodutide","sub":"Dual GLP-1/Glucagon Receptor Agonist | metabolic & Diabetes","desc":"Survodutide (Dual GLP-1/Glucagon Receptor Agonist | metabolic & Diabetes) appears in the historical reference index under metabolic, Metabolism Support, Cardiovascular. The original index associated it with these literature-review topics: Obesity Without Diabetes research topic, Obesity With Type 2 Diabetes research topic, Sustained Weight Management research topic, Metabolic Dysfunction-Associated Steatohepatitis (MASH) research topic, Liver Fat Reduction research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Obesity Without Diabetes research topic","Obesity With Type 2 Diabetes research topic","Sustained Weight Management research topic","Metabolic Dysfunction-Associated Steatohepatitis (MASH) research topic","Liver Fat Reduction research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: metabolic, Metabolism Support, Cardiovascular. Topics: Obesity Without Diabetes research topic, Obesity With Type 2 Diabetes research topic, Sustained Weight Management research topic, Metabolic Dysfunction-Associated Steatohepatitis (MASH) research topic, Liver Fat Reduction research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"metabolic, Metabolism Support, Cardiovascular","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"TB-4 Fragment","name":"TB-4 Fragment","sub":"Thymosin Beta-4 Fragment (Ac-SDKP)","desc":"TB-4 Fragment (Thymosin Beta-4 Fragment (Ac-SDKP)) appears in the historical reference index under Healing. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Healing. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Healing","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"TB-500","name":"TB-500","sub":"Ac-LKKTETQ | Synthetic Fragment (17-23) of Thymosin Beta-4","desc":"TB-500 (Ac-LKKTETQ | Synthetic Fragment (17-23) of Thymosin Beta-4) appears in the historical reference index under Healing. The original index associated it with these literature-review topics: tissue-repair research topic, Muscle Regeneration research topic, Tendon & Ligament Healing research topic, Wound Healing research topic, Athletic Recovery research topic, Neurological research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["tissue-repair research topic","Muscle Regeneration research topic","Tendon & Ligament Healing research topic","Wound Healing research topic","Athletic Recovery research topic","Neurological research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Healing. Topics: tissue-repair research topic, Muscle Regeneration research topic, Tendon & Ligament Healing research topic, Wound Healing research topic, Athletic Recovery research topic, Neurological research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-6°C","level":"well","category":"Healing","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/tb500/"},{"abbr":"Tesamorelin","name":"Tesamorelin","sub":"GHRH Analog | Visceral Fat Reduction","desc":"Tesamorelin (GHRH Analog | Visceral Fat Reduction) appears in the historical reference index under adipose metabolism. The original index associated it with these literature-review topics: metabolic research topic, HIV-Associated Lipodystrophy research topic, Selective Visceral Fat Targeting research topic, Sustained adipose metabolism research topic, Metabolic research topic, Muscle Growth research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["metabolic research topic","HIV-Associated Lipodystrophy research topic","Selective Visceral Fat Targeting research topic","Sustained adipose metabolism research topic","Metabolic research topic","Muscle Growth research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: adipose metabolism. Topics: metabolic research topic, HIV-Associated Lipodystrophy research topic, Selective Visceral Fat Targeting research topic, Sustained adipose metabolism research topic, Metabolic research topic, Muscle Growth research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Powder: 2-8°C | Reconstituted: 20-25°C","level":"emerging","category":"adipose metabolism","source":"Historical index source label: peptide.locker; primary-source verification required","url":"https://luviscience.com/product/tesamorelin/"},{"abbr":"Tesofensine","name":"Tesofensine","sub":"Tesofensine (Injectable Form)","desc":"Tesofensine (Tesofensine (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Room temperature","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"Thymalin","name":"Thymalin","sub":"Zinc-Dependent Thymic Nonapeptide | Immune Modulation & inflammation","desc":"Thymalin (Zinc-Dependent Thymic Nonapeptide | Immune Modulation & inflammation) appears in the historical reference index under Immune. The original index associated it with these literature-review topics: Immunity research topic, T-Cell Differentiation research topic, Suppressor T-Cell Enhancement research topic, NK Cell Activation research topic, Inflammation research topic, Anti Aging research topic, Neuroprotection research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Immunity research topic","T-Cell Differentiation research topic","Suppressor T-Cell Enhancement research topic","NK Cell Activation research topic","Inflammation research topic","Anti Aging research topic","Neuroprotection research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Immune. Topics: Immunity research topic, T-Cell Differentiation research topic, Suppressor T-Cell Enhancement research topic, NK Cell Activation research topic, Inflammation research topic, Anti Aging research topic, Neuroprotection research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"-20°C (lyophilized)","level":"emerging","category":"Immune","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Thymopentin","name":"Thymopentin","sub":"Thymopentin TP-5 (Thymopoietin Fragment)","desc":"Thymopentin (Thymopentin TP-5 (Thymopoietin Fragment)) appears in the historical reference index under Immune. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Immune. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Immune","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"Thymosin Alpha-1","name":"Thymosin Alpha-1","sub":"Synthetic Thymic Hormone | Immune System Modulation","desc":"Thymosin Alpha-1 (Synthetic Thymic Hormone | Immune System Modulation) appears in the historical reference index under Immune. The original index associated it with these literature-review topics: Immunity research topic, Primary Immunodeficiencies research topic, Vaccine Response Enhancement research topic, HIV/AIDS Immune Support research topic, Inflammation research topic, Recovery research topic, Anti Aging research topic, Cellular research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Immunity research topic","Primary Immunodeficiencies research topic","Vaccine Response Enhancement research topic","HIV/AIDS Immune Support research topic","Inflammation research topic","Recovery research topic","Anti Aging research topic","Cellular research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Immune. Topics: Immunity research topic, Primary Immunodeficiencies research topic, Vaccine Response Enhancement research topic, HIV/AIDS Immune Support research topic, Inflammation research topic, Recovery research topic, Anti Aging research topic, Cellular research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-6°C","level":"well","category":"Immune","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/thymosin-alpha-1-10mg/"},{"abbr":"Thymosin Beta-10","name":"Thymosin Beta-10","sub":"Thymosin Beta-10 Actin-Sequestering Peptide","desc":"Thymosin Beta-10 (Thymosin Beta-10 Actin-Sequestering Peptide) appears in the historical reference index under Healing. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Healing. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Healing","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"THY","name":"Thymulin","sub":"Humans | EPC pre-research with Tβ4 | Single transplantation | Improved cardiac function compared to control","desc":"Thymulin (Humans | EPC pre-research with Tβ4 | Single transplantation | Improved cardiac function compared to control) appears in the historical reference index under Immune Support, inflammation, Anti-Aging. The original index associated it with these literature-review topics: T-Cell Differentiation research topic, NK Cell Enhancement research topic, Cytokine Modulation research topic, NF-κB Inhibition research topic, Thymic Support research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["T-Cell Differentiation research topic","NK Cell Enhancement research topic","Cytokine Modulation research topic","NF-κB Inhibition research topic","Thymic Support research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: Immune Support, inflammation, Anti-Aging. Topics: T-Cell Differentiation research topic, NK Cell Enhancement research topic, Cytokine Modulation research topic, NF-κB Inhibition research topic, Thymic Support research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"well","category":"Immune Support, inflammation, Anti-Aging","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"TIR","name":"Tirzepatide","sub":"Dual GIP/GLP-1 Receptor Agonist | metabolic & Diabetes","desc":"Tirzepatide (Dual GIP/GLP-1 Receptor Agonist | metabolic & Diabetes) appears in the historical reference index under metabolic, Diabetes, Cardiovascular. The original index associated it with these literature-review topics: Severe Obesity Management research topic, Metabolic Syndrome Reversal research topic, Body Composition Optimization research topic, Type 2 Diabetes Management research topic, Insulin Resistance Improvement research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Severe Obesity Management research topic","Metabolic Syndrome Reversal research topic","Body Composition Optimization research topic","Type 2 Diabetes Management research topic","Insulin Resistance Improvement research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: metabolic, Diabetes, Cardiovascular. Topics: Severe Obesity Management research topic, Metabolic Syndrome Reversal research topic, Body Composition Optimization research topic, Type 2 Diabetes Management research topic, Insulin Resistance Improvement research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C","level":"extensive","category":"metabolic, Diabetes, Cardiovascular","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"Triptorelin","name":"Triptorelin","sub":"Triptorelin (GnRH Super-Agonist)","desc":"Triptorelin (Triptorelin (GnRH Super-Agonist)) appears in the historical reference index under Hormonal. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Hormonal. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Hormonal","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"TRT","name":"TRT","sub":"Testosterone Replacement Therapy | Testosterone Cypionate & Enanthate","desc":"TRT (Testosterone Replacement Therapy | Testosterone Cypionate & Enanthate) appears in the historical reference index under Hormone Restoration, Body Composition, Metabolic Health. The original index associated it with these literature-review topics: Hypogonadism research, Symptom Resolution research topic, Quality of Life research topic, Increased Lean Mass research topic, Reduced Fat Mass research topic. Its historical evidence label was 'extensive'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Hypogonadism research","Symptom Resolution research topic","Quality of Life research topic","Increased Lean Mass research topic","Reduced Fat Mass research topic"],"evidence":"Historical label: extensive — Broader literature footprint; independent review required","context":"Categories: Hormone Restoration, Body Composition, Metabolic Health. Topics: Hypogonadism research, Symptom Resolution research topic, Quality of Life research topic, Increased Lean Mass research topic, Reduced Fat Mass research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"20-25°C (room temp)","level":"extensive","category":"Hormone Restoration, Body Composition, Metabolic Health","source":"Historical index source label: pep-pedia; primary-source verification required","url":""},{"abbr":"VIP","name":"VIP","sub":"VIP (Injectable Form)","desc":"VIP (VIP (Injectable Form)) appears in the historical reference index under General peptide. The original index associated it with these literature-review topics: General peptide research. Its historical evidence label was 'Well Researched'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["General peptide research"],"evidence":"Historical label: Well Researched — Broader literature footprint; independent review required","context":"Categories: General peptide. Topics: General peptide research","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Refrigerated (2-8°C)","level":"Well Researched","category":"General peptide","source":"Historical index source label: Luvi Science; primary-source verification required","url":""},{"abbr":"Vitamin B12","name":"Vitamin B12","sub":"Methylcobalamin (Vitamin B12)","desc":"Vitamin B12 (Methylcobalamin (Vitamin B12)) appears in the historical reference index under Performance. The original index associated it with these literature-review topics: Research purposes. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Research purposes"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: Performance. Topics: Research purposes","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"Verify product label and primary sources","level":"emerging","category":"Performance","source":"Historical index source label: peptide.locker; primary-source verification required","url":""},{"abbr":"WSO","name":"Wolverine Stack","sub":"BPC-157 + TB-500 | tissue-repair & Recovery Protocol","desc":"Wolverine Stack (BPC-157 + TB-500 | tissue-repair & Recovery Protocol) appears in the historical reference index under tissue-repair, Wound Healing, inflammation. The original index associated it with these literature-review topics: Tendon & Ligament Healing research topic, Muscle Injury Recovery research topic, Joint Pain & Cartilage research topic, Accelerated Wound Closure research topic, Reduced Scarring research topic. Its historical evidence label was 'well'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Tendon & Ligament Healing research topic","Muscle Injury Recovery research topic","Joint Pain & Cartilage research topic","Accelerated Wound Closure research topic","Reduced Scarring research topic"],"evidence":"Historical label: well — Broader literature footprint; independent review required","context":"Categories: tissue-repair, Wound Healing, inflammation. Topics: Tendon & Ligament Healing research topic, Muscle Injury Recovery research topic, Joint Pain & Cartilage research topic, Accelerated Wound Closure research topic, Reduced Scarring research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"2-8°C (reconstituted)","level":"well","category":"tissue-repair, Wound Healing, inflammation","source":"Historical index source label: Luvi Science; primary-source verification required","url":"https://luviscience.com/product/wolverine-stack-20mg/"},{"abbr":"Zinc-Thymulin","name":"Zinc-Thymulin","sub":"Zinc-Dependent Thymic Nonapeptide | Immune Modulation & inflammation","desc":"Zinc-Thymulin (Zinc-Dependent Thymic Nonapeptide | Immune Modulation & inflammation) appears in the historical reference index under hair-follicle. The original index associated it with these literature-review topics: Immunity research topic, T-Cell Differentiation research topic, Suppressor T-Cell Enhancement research topic, NK Cell Activation research topic, Inflammation research topic, Anti Aging research topic, Neuroprotection research topic. Its historical evidence label was 'emerging'; this is presented as indexing metadata, not an efficacy claim. Researchers must verify methods, findings, limitations and relevance against primary sources.","uses":["Immunity research topic","T-Cell Differentiation research topic","Suppressor T-Cell Enhancement research topic","NK Cell Activation research topic","Inflammation research topic","Anti Aging research topic","Neuroprotection research topic"],"evidence":"Historical label: emerging — Emerging or preclinical literature; independent review required","context":"Categories: hair-follicle. Topics: Immunity research topic, T-Cell Differentiation research topic, Suppressor T-Cell Enhancement research topic, NK Cell Activation research topic, Inflammation research topic, Anti Aging research topic, Neuroprotection research topic","scope":"Original amount, route and schedule fields are not reproduced; no protocol recommendation is provided","storage":"-20°C (lyophilized)","level":"emerging","category":"hair-follicle","source":"Historical index source label: peptide.locker; primary-source verification required","url":""}]